Department of Organic Chemistry, University of Debrecen, P.O. Box 400, H-4002 Debrecen, Hungary.
Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
Molecules. 2018 Mar 15;23(3):666. doi: 10.3390/molecules23030666.
The aim of the present study was to broaden the structure-activity relationships of - and -β-d-glucopyranosyl azole type inhibitors of glycogen phosphorylase. 1-Aryl-4-β-d-gluco-pyranosyl-1,2,3-triazoles were prepared by copper catalyzed azide-alkyne cycloadditions between -perbenzylated or -peracetylated β-d-glucopyranosyl ethynes and aryl azides. 1-β-d-Gluco-pyranosyl-4-phenyl imidazole was obtained in a glycosylation of 4(5)-phenylimidazole with -peracetylated α-d-glucopyranosyl bromide. -β-d-Glucopyranosyl--substituted-tetrazoles were synthesized by alkylation/arylation of -perbenzoylated 5-β-d-glucopyranosyl-tetrazole or from a 2,6-anhydroheptose tosylhydrazone and arenediazonium salts. 5-Substituted tetrazoles were glycosylated by -peracetylated α-d-glucopyranosyl bromide to give -β-d-glucopyranosyl--substituted-tetrazoles. Standard deprotections gave test compounds which were assayed against rabbit muscle glycogen phosphorylase . Most of the compounds proved inactive, the best inhibitor was 2-β-d-glucopyranosyl-5-phenyltetrazole (IC 600 μM). These studies extended the structure-activity relationships of β-d-glucopyranosyl azole type inhibitors and revealed the extreme sensitivity of such type of inhibitors towards the structure of the azole moiety.
本研究旨在拓宽 -和-β-D-吡喃葡萄糖基唑类糖原磷酸化酶抑制剂的结构-活性关系。通过铜催化的 -全保护或 -全乙酰化β-D-吡喃葡萄糖基炔烃与芳基叠氮化物之间的叠氮化物-炔烃环加成反应,制备了 1-芳基-4-β-D-吡喃葡萄糖基-1,2,3-三唑。通过 4(5)-苯基咪唑与 -全乙酰化的α-D-吡喃葡萄糖基溴化物的糖苷化反应,得到了 1-β-D-吡喃葡萄糖基-4-苯基咪唑。-β-D-吡喃葡萄糖基--取代的四唑通过 -全苯甲酰化的 5-β-D-吡喃葡萄糖基-四唑的烷基化/芳基化或从 2,6-脱水庚糖对甲苯磺酰腙和芳基重氮盐合成。5-取代的四唑通过 -全乙酰化的α-D-吡喃葡萄糖基溴化物糖苷化得到 -β-D-吡喃葡萄糖基--取代的四唑。标准脱保护得到测试化合物,然后对兔肌肉糖原磷酸化酶进行测定。大多数化合物证明没有活性,最好的抑制剂是 2-β-D-吡喃葡萄糖基-5-苯基四唑(IC 600 μM)。这些研究扩展了 -D-吡喃葡萄糖基唑类抑制剂的结构-活性关系,并揭示了此类抑制剂对唑基部分结构的极端敏感性。